Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tenax Therapeutics (TENX)
NASDAQ:TENX
Tenax Therapeutics (TENX) Stock Price & Analysis
480 Followers
TENX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.77 - $61.20
Previous Close$3.34
Volume10.14K
Average Volume (3M)24.48K
Market Cap
$6.55M
Enterprise Value$6.96M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$413.17K
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Aug 19, 2024EPS Estimate
-$1.99Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-24.54
Shares Outstanding1,958,245
10 Day Avg. Volume23,825
30 Day Avg. Volume24,478
Standard Deviation0.32
R-Squared0.13
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.44
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.82
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tenax Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TENX FAQ
What was Tenax Therapeutics’s price range in the past 12 months?
Tenax Therapeutics lowest stock price was $2.77 and its highest was $61.20 in the past 12 months.
What is Tenax Therapeutics’s market cap?
Currently, no data Available
When is Tenax Therapeutics’s upcoming earnings report date?
Tenax Therapeutics’s upcoming earnings report date is Aug 19, 2024 which is in 32 days.
How were Tenax Therapeutics’s earnings last quarter?
Tenax Therapeutics released its earnings results on May 14, 2024. The company reported -$3.12 earnings per share for the quarter, missing the consensus estimate of -$2.4 by -$0.72.
Is Tenax Therapeutics overvalued?
According to Wall Street analysts Tenax Therapeutics’s price is currently Overvalued.
Does Tenax Therapeutics pay dividends?
Tenax Therapeutics does not currently pay dividends.
What is Tenax Therapeutics’s EPS estimate?
Tenax Therapeutics’s EPS estimate is -$1.99.
How many shares outstanding does Tenax Therapeutics have?
Tenax Therapeutics has 1,958,245 shares outstanding.
What happened to Tenax Therapeutics’s price movement after its last earnings report?
Tenax Therapeutics reported an EPS of -$3.12 in its last earnings report, missing expectations of -$2.4. Following the earnings report the stock price went down -2.254%.
Which hedge fund is a major shareholder of Tenax Therapeutics?
Currently, no hedge funds are holding shares in TENX
---
Tenax Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
TENX Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.80%
12-Months-Change
Fundamentals
Return on Equity
-75.66%
Trailing 12-Months
Asset Growth
-5.31%
Trailing 12-Months
Company Description
Tenax Therapeutics
Tenax Therapeutics, Inc. is a pharmaceutical company, which engages in the identification, development, and commercialization of novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.
---
TENX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering TENX
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-67.13%
reiterated a buy rating 5 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -67.13% per trade.
---